Heart disease is a common and serious condition for people with diabetes, but with the information, tools and medications we have available today, heart disease is not only treatable but preventable.
read more →
Jeremy Pettus explains the pros and cons of SGLT2s for people with type 1, and offers advice on how to try them safely and smartly.
read more →
The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
We should all do what we can to keep our hearts healthy and happy. If you have type 2 diabetes, you are at an even higher risk of having heart disease. The good news is there is a lot you can do to prevent it!
read more →
